Skip to main content

ACS & ASCO are Stronger Together: Cancer.Net content is now available on


Pancreatic Neuroendocrine Tumor Risk Factors

A risk factor is anything that increases your chance of getting a disease such as cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like a person’s age or family history, can’t be changed.

But having a risk factor, or even many risk factors, does not mean that you will get the disease. And some people who get the disease may have few or no known risk factors.

Several factors can affect a person’s chance of getting a neuroendocrine tumor (NET) of the pancreas.

Risk factors that can be changed


Smoking is a risk factor for pancreatic NETs. Most research shows that heavy smoking increases risk, but some studies show that any history of smoking could put you at risk. 


Some studies have shown a link between heavy alcohol use and pancreatic NETs. This link appears to be mostly related to functioning pancreatic NETs rather than nonfunctioning pancreatic NETs. Heavy alcohol use can also lead to conditions such as chronic pancreatitis, which may increase pancreatic NET risk.

Risk factors that can’t be changed

Family history

Pancreatic NETs seem to run in some families. In some of these families, the high risk is due to an inherited syndrome (explained below). In other families, the gene causing the increased risk is not known. If family history is a risk factor, it usually involves a first degree relative (parent, sibling, child), a family history of pancreatic NET, or a family history of any cancer. 

Inherited genetic syndromes

Inherited gene changes (mutations) can be passed from parent to child. Sometimes these changes result in syndromes that include increased risks of other cancers (or other health problems).

Pancreatic neuroendocrine tumors and cancers can also be caused by genetic syndromes, such as:

  • Neurofibromatosis, type 1, which is caused by mutations in the NF1 gene. This syndrome leads to an increased risk of many tumors, including somatostatinomas.
  • Multiple endocrine neoplasia, type I (MEN1), caused by mutations in the MEN1 gene. This syndrome leads to an increased risk of tumors of the parathyroid gland, the pituitary gland, and the islet cells of the pancreas.
  • Von Hippel-Lindau (VHL) syndrome, which is caused by mutations in the VHL gene. This syndrome leads to an increased risk of many tumors, including pancreatic NETs.

Changes in the genes that cause some of these syndromes can be found by genetic testing. For more information on genetic testing, see Can Pancreatic Neuroendocrine Tumor Be Found Early?


Pancreatic NETs are more common in people with diabetes. The reason for this is not known. Most of the risk is found in people with type 2 diabetes. This type of diabetes most often starts in adulthood and is often related to being overweight or obese. It’s not clear if people with type 1 (juvenile) diabetes have a higher risk.

Chronic pancreatitis

Chronic pancreatitis, a long-term inflammation of the pancreas, is linked with an increased risk of pancreatic NETs. If chronic pancreatitis is because of heavy alcohol use, then stopping alcohol may help decrease the risk of pancreatic NETs. 

Factors with unclear effect on risk

Being overweight or obese

Being overweight or obese could be a risk factor for pancreatic NET. Studies so far are inconclusive.


Some older studies have suggested that drinking coffee might increase the risk of pancreatic NET, but more recent studies have not confirmed this.

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.

Ben Q, Zhong J, Fei J, et al. Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study. Scientific Reports. 2016;6:36073. doi:10.1038/srep36073.

Cancer.Net. Von Hippel-Lindau Syndrome. 12/2017. Accessed at  on October 8, 2018.

Haugvik SP, Hedenström P, Korsæth E, et al. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Neuroendocrinology. 2015;101(2):133-42. doi: 10.1159/000375164. Epub 2015 Jan 22.

Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2016 Jan;27(1):68-81. doi: 10.1093/annonc/mdv505. Epub 2015 Oct 20.

National Cancer Institute. Physician Data Query (PDQ). Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment – Patient Version. 2018. Accessed at on October 7, 2018.

Valente R, Hayes AJ, Haugvik SP, et al. Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms. Endocr Relat Cancer. 2017 Aug;24(8):405-414. doi: 10.1530/ERC-17-0040. Epub 2017 May 31.

Vinik A, Perry RR, Hughes MS, et al. Multiple Endocrine Neoplasia Type 1. [Updated 2017 Oct 7]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000-. Available from: Accessed October 9, 2018.

Last Revised: October 30, 2018

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.